Analysts Are Neutral on These Real Estate Stocks: Sabra Healthcare REIT (SBRA), Safehold (SAFE)
Analysts fell to the sidelines weighing in on Sabra Healthcare REIT (SBRA – Research Report), Safehold (SAFE – Research Report) and Terreno Realty (TRNO – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sabra Healthcare REIT (SBRA)
Scotiabank analyst Nicholas Yulico maintained a Hold rating on Sabra Healthcare REIT today and set a price target of $20.00. The company’s shares closed last Wednesday at $18.20.
According to TipRanks.com, Yulico is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $20.40 average price target, a 13.8% upside from current levels. In a report released yesterday, BMO Capital also maintained a Hold rating on the stock with a $22.00 price target.
See the top stocks recommended by analysts >>
Safehold (SAFE)
Truist Financial analyst Michael Lewis maintained a Hold rating on Safehold today. The company’s shares closed last Wednesday at $14.38.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of
Safehold has an analyst consensus of Moderate Buy, with a price target consensus of $20.75.
Terreno Realty (TRNO)
In a report released today, Greg McGinniss from Scotiabank maintained a Hold rating on Terreno Realty, with a price target of $61.00. The company’s shares closed last Wednesday at $58.01.
According to TipRanks.com, McGinniss is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Terreno Realty with a $63.00 average price target.
Read More on SBRA:
Disclaimer & DisclosureReport an Issue
- Sabra Healthcare REIT: Balancing Strong FAD Performance with Capital Cost Challenges
- Sabra Healthcare REIT Reports Q3 Results and Upgraded Rating
- Sabra Health Care sees 2025 adjusted FFO $1.495-$1.505, consensus $1.50
- Sabra Health Care reports Q3 adjusted FFO 38c, consensus 38c
- SBRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
